Skip to main content
. 2023 Jan 21;15(2):374. doi: 10.3390/pharmaceutics15020374

Table 2.

Antiproliferative activity (IC50, nM) of DOXO and CyD polymers in SK-N-SH and PMA stimulated SK-N-SH-PMA cells.

Cell Line DOXO DOXO/
HALβCyD
8/1
DOXO/
HAHβCyD
8/1
DOXO/
HALβCyD
16/1
DOXO/
HAHβCyD
16/1
SK-N-SH 79.3 ± 23.5 83.5 ± 21.4 92.3 ± 13.4 22.1 ± 9.8 a 24.6 ± 8.5 a
SK-N-SH-PMA 82.7 ± 11.9 58.8 ± 13.4 b 40.7 ± 13.8 a,c 25.3 ± 8.7 a 26.2 ± 3.9 a

ap < 0.001 vs. DOXO, b p < 0.021 vs. DOXO, c p < 0.001 vs. cells SK-N-SH treated with DOXO/HAHβCyD 8/1.